Please use this identifier to cite or link to this item:
https://hdl.handle.net/2440/126534
Citations | ||
Scopus | Web of Science® | Altmetric |
---|---|---|
?
|
?
|
Type: | Journal article |
Title: | Cost effectiveness of treatment models of care for hepatitis C: the South Australian state-wide experience |
Author: | Ramachandran, J. Kaambwa, B. Muller, K. Haridy, J. Tse, E. Tilley, E. Altus, R. Waddell, V. Gordon, D. Shaw, D. Huynh, D. Stewart, J. Nelson, R. Warner, M. Boyd, M.A. Chinnaratha, M.A. Harding, D. Ralton, L. Colman, A. Woodman, R. et al. |
Citation: | European Journal of Gastroenterology and Hepatology, 2020; 32(10):1381-1389 |
Publisher: | Wolters Kluwer |
Issue Date: | 2020 |
ISSN: | 0954-691X 1473-5687 |
Statement of Responsibility: | Jeyamani Ramachandran, Billingsley Kaambwa, Kate Muller, James Haridy, Edmund Tse, Emma Tilley, Rosalie Altus, Victoria Waddell, David Gordon, David Shaw, Dep Huynh, Jeffrey Stewart, Renjy Nelson, Morgyn Warner, Mark A. Boyd, Mohamed A. Chinnaratha, Damian Harding, Lucy Ralton, Anton Colman, Richard Woodman and Alan J. Wigg |
Abstract: | Abstract not available. |
Keywords: | Cost effectiveness; directly acting antiviral drugs; hepatitis C; Markov model; models of care |
Rights: | Copyright © 2019 Wolters Kluwer Health, Inc. All rights reserved. |
DOI: | 10.1097/MEG.0000000000001659 |
Published version: | http://dx.doi.org/10.1097/meg.0000000000001659 |
Appears in Collections: | Aurora harvest 4 Medicine publications |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.